- Home
- VZLA vs TNDM Comparison
VZLA vs TNDM Comparison
Compare VZLA & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VZLA | TNDM |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | VZLA | TNDM |
|---|---|---|
| Price | $3.76 | $22.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 19 |
| Target Price | $7.00 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 5.1M | 2.2M |
| Earning Date | 12-12-2025 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | N/A | $8.11 |
| Revenue Next Year | N/A | $11.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $2.88 | $10.25 |
| 52 Week High | $7.19 | $29.65 |
Technical Indicators
Market Signals| Indicator | VZLA | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 61.61 | 67.36 |
| Support Level | $3.21 | $19.70 |
| Resistance Level | $3.95 | $24.23 |
| Average True Range (ATR) | 0.15 | 1.31 |
| MACD | 0.05 | 0.35 |
| Stochastic Oscillator | 79.26 | 80.09 |
Price Performance
Historical ComparisonAbout VZLA Vizsla Silver Corp.
Vizsla Silver Corp is the exploration of mineral properties. The company currently conducts substantially all its operations in Canada and Mexico in one reportable segment. The company has one reportable segment, mainly mineral exploration, evaluation and development. Its project includes Panuco Project.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.